CVS Health Corporation (CVS) has a MoatMap StockRank of 92/100 based on Quality (43/100), Value (52/100), and Momentum (83/100) factor scores. The current signal is STRONG BUY. CVS Health is facing severe structural headwinds in its pharmacy benefit management and insurance segments, resulting in a low quality score of 43. It fails the Terry Smith lens of owning high-ROIC, clean business models.
CVS Health Corporation is an integrated healthcare company operating retail pharmacies (CVS Pharmacy), pharmacy benefit management services (CVS Caremark), and health insurance plans (Aetna). Its competitive moat is built on unmatched scale and vertical integration across pharmacy, PBM, and insurance segments, creating a comprehensive healthcare ecosystem. CVS Health is one of the largest integrated healthcare providers in the U.S., offering a broad range of health services.
| Price | $94.82 |
| Market Cap | $118.6B |
| P/E (TTM) | 41.59 |
| P/E (Forward) | 11.33 |
| Price/Book | 1.56 |
| Return on Equity | 3.8% |
| Return on Invested Capital | 3.2% |
| Debt/Equity | 100.91 |
| Gross Margin | 13.4% |
| Operating Margin | 4.1% |
| Revenue Growth | 6.1% |
| Dividend Yield | 2.8% |
| Free Cash Flow | $5.2B |
CVS Health Corporation operates in the Healthcare Plans industry, part of the Healthcare sector (United States).